Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.

MLA

Ferraro, Alastair J., et al. “Relapsed Wegener’s Granulomatosis after Rituximab Therapy--B Cells Are Present in New Pathological Lesions despite Persistent ‘Depletion’ of Peripheral Blood.” Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 23, no. 9, Sept. 2008, pp. 3030–32. EBSCOhost, https://doi.org/10.1093/ndt/gfn318.

APA

Ferraro, A. J., Smith, S. W., Neil, D., & Savage, C. O. S. (2008). Relapsed Wegener’s granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent “depletion” of peripheral blood. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 23(9), 3030–3032. https://doi.org/10.1093/ndt/gfn318

Chicago

Ferraro, Alastair J, Stuart W Smith, Desley Neil, and Caroline O S Savage. 2008. “Relapsed Wegener’s Granulomatosis after Rituximab Therapy--B Cells Are Present in New Pathological Lesions despite Persistent ‘Depletion’ of Peripheral Blood.” Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 23 (9): 3030–32. doi:10.1093/ndt/gfn318.